Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN)

Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN)

Background: Gestational trophoblastic disease includes a rare group of benign and malignant tumors derived from abnormal trophoblastic proliferation. Malignant forms are called gestational trophoblastic neoplasia (GTN) and include invasive mole, choriocarcinoma, placental site trophoblastic tumor an...

Full description

Bibliographic Details
Main Authors: Giorgia Mangili, Giulia Sabetta, Raffaella Cioffi, Emanuela Rabaiotti, Giorgio Candotti, Francesca Pella, Massimo Candiani, Alice Bergamini
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
gestational trophoblastic neoplasia
immunotherapy
PD-1/PD-L1 inhibitors
Pembrolizumab
Avelumab
Camrelizumab
Online Access:https://www.mdpi.com/2072-6694/14/11/2782

Internet

https://www.mdpi.com/2072-6694/14/11/2782

Similar Items